| Source HCPCS Code |
|
Target NDC Code |
J9227
IJ, isatuximab-irfc, 10 mg
|
⇄
|
00024-0654-01
SARCLISA 100 MG/5 ML VIAL
|
| Detail Information |
| Relationship Start Date |
10/01/2020 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9227
IJ, isatuximab-irfc, 10 mg
|
⇄
|
00024-0656-01
SARCLISA 500 MG/25 ML VIAL
|
| Detail Information |
| Relationship Start Date |
10/01/2020 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
25 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J9227
Inj. isatuximab-irfc 10 mg
|
⇄
|
00024-0654-01
Sarclisa
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J9227
Inj. isatuximab-irfc 10 mg
|
⇄
|
00024-0656-01
Sarclisa
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|